News
Earlier interventions can improve financial literacy, especially for women - who are at higher risk due to lower initial literacy levels, lower retirement wealth and longer lifetimes.
But as Earth Day approaches, the decline in regulatory protections and support for energy transition leaves investors ...
Active ETFs being cheaper lowers their hurdle rate, and lower fees are always going to tip the odds in investors’ favor. ETFs ...
While there undoubtedly are some undervalued companies among the thousands of smaller stocks on Wall Street, the sector as a whole is not cheaper than the large-cap sector, even though small caps have ...
A federal judge temporarily halted DOGE from accessing Social Security data late Thursday night with a preliminary injunction in a lawsuit brought forth by labor groups. The plaintiffs argue DOGE is ...
President Donald Trump is unlikely to follow through on his threat to fire Federal Reserve Chairman Jerome Powell - but the pressure from his public campaign for lower interest rates will still have ...
The following are median forecasts for next week's U.S. data from a survey compiled by The Wall Street Journal. (END) Dow Jones Newswires ...
The bad news is that President Donald Trump's latest threats against the independence of the Federal Reserve raise the risks to your investments. The threats themselves are bad enough. But the ...
It had become something of a cliché to say that investors hate uncertainty - at least until the confusion surrounding President Donald Trump's on-again, off-again tariff plans left them grasping for a ...
If the recent past is any guide, an indicator known as the "Smart Money Flow Index" might be flashing a market buy signal, said Jim Paulsen, a market veteran and former top strategist at the Leuthold ...
Trump has slapped 25% tariffs on goods from both Mexico and Canada, but later suspended those levies on products that fall under the two countries' trade agreement with the U.S. Still, many products ...
Eli Lilly & Co.'s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results